Skip to Content
Merck
  • The identification of (E)-2-methylglutaconic acid, a new isoleucine metabolite, in the urine of patients with beta-ketothiolase deficiency, propionic acidaemia and methylmalonic acidaemia.

The identification of (E)-2-methylglutaconic acid, a new isoleucine metabolite, in the urine of patients with beta-ketothiolase deficiency, propionic acidaemia and methylmalonic acidaemia.

Biomedical mass spectrometry (1982-01-01)
M Duran, L Bruinvis, D Ketting, J P Kamerling, S K Wadman, R B Schutgens
ABSTRACT

The identification of (E)-2-methylglutaconic acid, a 'new' metabolite of isoleucine, is described. The substance was detected in urine samples from patients with propionic acidaemia, methylmalonic acidaemia and so-called beta-ketothiolase deficiency; in the majority of cases together with N-tiglylglycine. (E)-2-Methylglutaconic acid is thought to be the end product of the 3-methylcrotonyl-CoA carboxylase-catalysed carboxylation of tiglyl-CoA. Prerequisites for the quantitative gas chromatographic analysis of the unstable 2- (and 3-) methyl-glutaconic acid ditrimethylsilyl ester are given.

MATERIALS
Product Number
Brand
Product Description

Supelco
(Z)-3-Methylglutaconic acid, ≥97.0% (HPLC)
Supelco
(E)-3-Methylglutaconic acid, ≥97.0% (HPLC)